Update on pediatric bone health

Journal of the American Osteopathic Association

Volumn 109, Issue 1, 2009, Pages 5-12

  Henwood, Maria J ^a   Binkovitz, Larry ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID; PARATHYROID HORMONE; VITAMIN D; VITAMIN K GROUP;

ADOLESCENT; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASE; BONE GROWTH; BONE MINERALIZATION; CALCIUM HOMEOSTASIS; CHILD; CHILDHOOD CANCER; CHRONIC DISEASE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; JAW OSTEONECROSIS; LIFESTYLE; NUTRITION; OSTEOPOROSIS; PEDIATRICS; PREVENTION AND CONTROL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEIZURE; VITAMIN SUPPLEMENTATION;

ABSORPTIOMETRY, PHOTON; ANIMALS; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; CALCIUM; CHILD; DIET; HOMEOSTASIS; HUMANS; LIFE STYLE; MILK; NUTRITIONAL STATUS; OSTEOPOROSIS; RISK FACTORS;

EID: 59949101049     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Fast facts on osteoporosis. National Osteopathic Foundation Web site. Available at: http://www.nof.org/osteoporosis/diseasefacts.htm. Accessed January 9, 2009.
2. Bianchi ML. Osteoporosis in children and adolescents [review] [published online ahead of print July 18, 2007]. Bone. 2007;41:486-495.
3. Misra M. Long-term skeletal effects of eating disorders with onset in adolescence [review]. Ann NY Acad Sci. 2008;1135:212-218.
4. Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics. 2008;121:e705-e713. Available at: http://pediatrics.aappublications.org/cgi/ content/full/121/3/e705. Accessed November 18, 2008.
5. Otis CL, Drinkwater B, Johnson M, Loucks A, Wilmore J. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc. May 1997;29(5):i-ix.
6. Beals KA, Meyer NL. Female athlete triad update. Clin Sports Med. 2007;26:69-89.
7. Infante D, Tormo R. Risk of inadequate bone mineralization in diseases involving long-term suppression of dairy products. J Pediatr Gastroenterol Nutr. 2000;30:310-313.
8. Gordon CL, Halton JM, Atkinson SA, Webber CE. The contributions of growth and puberty to peak bone mass. Growth Dev Aging. 1991;55:257-262.
9. Fuchs RK, Bauer JJ, Snow CM. Jumping improves hip and lumbar spine bone mass in prepubescent children: a randomized controlled trial. J Bone Miner Res. 2001;16:148-156.
10. MacKelvie KJ, Khan KM, Petit MA, Janssen PA, McKay HA. A school-based exercise intervention elicits substantial bone health benefits: a 2-year randomized controlled trial in girls. Pediatrics. 2003;112(6 pt 1):e447. Available
11. at: http://pediatrics.aappublications.Org/cgi/content/full/112/6/e447. Accessed November 14, 2008.
12. Sparks JW. Human intrauterine growth and nutrient accretion [review]. Semin Perinatol. 1984;8:74-93.
13. Rigo J, De Curtis M. Disorders of calcium, phosphorus and magnesium metabolism. In: Martin RJ, Fanaroff AA, Walsh MC. Faranoff and Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 8th ed. Philadelphia, Pa: Elsevier; 2006:1491-1522.
14. Janz K. Physical activity and bone development during childhood and adolescence. Implications for the prevention of osteoporosis. Minerva Pediatr. 2002;54:93-104.
15. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest. 1994;93:799-808. Available at: http://www.jci.org/articles/view/ 117034. Accessed January 8, 2009.
16. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, et al. Peak bone mass [review]. Osteoporos Int. 2000;11:985-1009.
17. Davies JH, Evans BA, Gregory JW. Bone mass acquisition in healthy children [review]. Arch Dis Child. 2005;90:373-378. Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1720329&blobtype=p http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1720329&blobtype=pdf. Accessed January 8, 2009.
18. Diaz R. Calcium disorders in children and adolescents. In: Lifshitz F, ed. Pediatric Endocrinlogy. 5th ed. New York, NY: Informa Healthcare USA, Inc; 2007:475-495. Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders; vol 2.
19. Prevention: who's at risk? National Osteopathic Foundation Web site. Available at: http://www.nof.org/prevention/risk.htm. Accessed January 9, 2009.
20. Pluskiewicz W, Adamczyk P, Drozdzowska B, Szprynger K, Szczepanska M, Halaba Z, et al. Skeletal status in adolescents with end-stage renal failure: a longitudinal study. Osteoporos Int. 2005;16:289-295.
21. Williams SE, Seidner DL. Metabolic bone disease in gastrointestinal illness. Gastroenterol Clin North Am. 2007;36:161-190,viii.
22. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab. 2005;90:1888-1896. Available at: http://jcem.endojournals.org/cgi /con-tent/full/90/3/1888. Accessed November 14, 2008.
23. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab. 1996;81:3077-3083. Available at: http://jcem.endojournals. org/cgi/reprint /81/8/3077. Accessed November 14, 2008.
24. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest. 2000;23:295-303.
25. Mora S, Weber G, Marenzi K, Signorini E, Rovelli R, Proverbio MC, et al. Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment. J Bone Miner Res. 1999;14:1971-1977.
26. Plotkin H, Sueiro R. Osteoporosis in children with neuromuscular diseases and inborn errors of metabolism [review]. Minerva Pediatr. 2007;59:129-135.
27. Canalis E. Mechanisms of glucocorticoid-induced osteoporosis [review]. Curr Opin Rheumatol. 2003;15:454-457.
28. Rehman Q, Lane NE. Effect of glucocorticoids on bone density [review]. Med Pediatr Oncol. 2003;41:212-216.
29. Fitzpatrick LA. Pathophysiology of bone loss in patients receiving anti convulsant therapy. Epilepsy Behav. 2004;5(suppl 2):S3-S15.
30. Pack AM, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs [review]. Cleve Clin J Med. 2004;71(suppl 2):S42-S48.
31. Kaste SC. Bone-mineral density deficits from childhood cancer and its therapy. A review of at-risk patient cohorts and available imaging methods [review] [published online ahead of print February 12, 2004]. Pediatr Radiol. 2004;34:373-378.
32. Kranz S, Lin PJ, Wagstaff DA. Children's dairy intake in the United States: too little, too fat [published online ahead of print July 24, 2007]? J Pediatr. 2007;151:642-646.
33. Childhood obesity in the United States: facts and figures. Institutes of Medicine Web site. September 2004. Available at: http://www.iom.edu/Object. File/Master/22/606/FINALfactsandfigures2.pdf. Accessed November 20, 2008.
34. Black RE, Williams SM, Jones IE, Goulding A. Children who avoid drinking cow milk have low dietary calcium intakes and poor bone health. Am J Clin Nutr. 2002;76:675-680. Available at: http://www.ajcn.org/cgi/content/full/ 76/3/675. Accessed November 17, 2008.
35. Goulding A. Risk factors for fractures in normally active children and adolescents. Med Sport Sci. 2007;51:102-120.
36. National Youth Risk Behavior Survey: 1991-2005. Trends in the Prevalence of Alcohol Use. Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/HealthyYouth/yrbs/pdf/trends/2005-YRBS-Alcohol-Use.pdf. Accessed November 19, 2008.
37. Adolescent smoking statistics. American Lung Association Web site. November 2003. Available at: http://www.lungusa.org/site/pp.asp?c=dvLUK 9O0E&b=39868. Accessed November 19, 2008.
38. Klein RF. Alcohol-induced bone disease: impact of ethanol on osteoblast proliferation [review]. Alcohol Clin Exp Res. 1997;21:392-399.
39. Chakkalakal DA. Alcohol-induced bone loss and deficient bone repair [review]. Alcohol Clin Exp Res. 2005;29:2077-2090.
40. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int. 2001;68:259-270.
41. Friedman AW. Important determinants of bone strength: beyond bone mineral density [review]. J Clin Rheumatol. 2006;12:70-77.
42. Taskinen M, Saarinen-Pihkala UM, Hovi L, Vettenranta K, Ma&doe;kitie O. Bone health in children and adolescents after allogeneic stem cell transplantation: high prevalence of vertebral compression fractures. Cancer. 2007;110:442-451.
43. Binkovitz LA, Henwood MJ. Pediatric DXA: technique and interpretation [review]. Pediatr Radiol. 2007;37:21-31. Available at: http://www.pubmed central.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16715219. Accessed November 17, 2008.
44. Mølgaard C, Thomsen BL, Prentice A, Cole TJ, Michaelsen KF. Whole body bone mineral content in healthy children and adolescents. Arch Dis Child. 1997;76:9-15. Available at: http://www.pubmedcentral.nih.gov/ picrender .fcgi?artid=1717036&blobtype=pdf. Accessed November 17, 2008.
45. Southard RN, Morris JD, Mahan JD, Hayes JR, Torch MA, Sommer A, Zipf WB. Bone mass in healthy children: measurement with quantitative DXA. Radiology. 1991;179:735-738. Available at: http://radiology.rsnajnls.org/ cgi /reprint/179/3/735. Accessed January 8, 2009.
46. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. World Health Organ Tech Rep Ser. 1994;843:1-129.
47. Leonard MB, Shults J, Elliott DM, Stallings VA, Zemel BS. Interpretation of whole body dual energy X-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography. Bone. 2004;34:1044-1052.
48. Dietary supplement fact sheet: calcium. National Institutes of Health Web site. Available at: http://dietary-supplements.info.nih.gov/factsheets /calcium.asp. Accessed November 20, 2008.
49. Moore LL, Bradlee ML, Gao D, Singer MR. Effects of average childhood dairy intake on adolescent bone health [published online ahead of print August 13, 2008]. J Pediatr. 2008;153:667-673.
50. Greer FR, Krebs NF; American Academy of Pediatrics Committee on Nutrition. Optimizing bone health and calcium intakes of infants, children, and adolescents. Pediatrics. 2006;117:578-585. Available at: http://pediatrics.aap publications.org/cgi/content/full/117/2/578. Accessed January 8, 2009.
51. Gartner LM, Greer FR; Section on Breastfeeding and Committee on Nutrition. American Academy of Pediatrics. Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. Pediatrics. 2003;111:908-910. Available at: http://pediatrics.aappublications.org/cgi/ content/full/111/4/908. Accessed November 17, 2008.
52. Wagner CL, Greer FR; Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122:1142-1152. Available at: http://aappolicy.aap publications.org/cgi/content/full/pediatrics;122/5/1142. Accessed November 18, 2008.
53. Gordon CA. Vitamin D: what is the optimal level in children? Abstract presented at: Fourth International Conference on Children's Bone Health; June 21-24, 2007; Montreal, Canada.
54. Gilsanz V, Wren TA, Sanchez M, Dorey F, Judex S, Rubin C. Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J Bone Miner Res. 2006;21:1464-1474.
55. Gusi N, Raimundo A, Leal A. Low-frequency vibratory exercise reduces the risk of bone fracture more than walking: a randomized controlled trial. BMC Musculoskelet Disord. November 30, 2006;7:9. Available at: http://www.pub medcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17137514. Accessed November 17, 2008.
56. Kavak US, Yüce A, Koçak N, Demir H, Saltik IN, Güraken F, et al. Bone mineral density in children with untreated and treated celiac disease. J Pediatr Gastroenterol Nutr. 2003;37:434-436.
57. Leonard MB. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease [review]. Pediatrics. 2007;119(suppl 2):S166-S174. Available at: http://pediatrics.aappublications.org/cgi/content/full/119 /Supplement-2/S166. Accessed November 17, 2008.
58. Osteoporosis prevention, diagnosis, and therapy [review]. NIH Consens Statement. 2000 March 27-29;17(1):1-45.
59. Glorieux FH. Experience with bisphosphonates in osteogenesis imper-fecta. Pediatrics. 2007;119(suppl 2):S163-S165. Available at: http://pediatrics.aappublications.org/cgi/content/full/119/Supplement-2/S163. Accessed November 17, 2008.
60. Sholas MG, Tann B, Gaebler-Spira D. Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series. J Pediatr Orthop. 2005;25:326-331.
61. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy [review] [published online ahead of print June 14, 2007]. OsteoporosInt. 2007;18:1319-1328.
62. Bauman WA, Wecht JM, Kirshblum S, Spungen AM, Morrison N, Cirnigliaro C, et al. Effect of pamidronate administration on bone in patients with acute spinal cord injury. J Rehabil Res Dev. 2005;42:305-313.
63. Noguera A, Ros JB, Pavía C, Alcover E, Valls C, Villaronga M, et al. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol Metab. 2003;16:529-536.
64. Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr. 2002;141:644-651.
65. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imper-fecta. N Engl J Med. 1998;339:947-952.
66. Devogelaer JP, Coppin C. Osteogenesis imperfecta: current treatment options and future prospects. Treat Endocrinol. 2006;5:229-242.
67. Andiran N, Alikasifoglu A, Gonc N, Ozon A, Kandemir N, Yordam N. Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation. J Pediatr Endocrinol Metab. 2008;21:63-72.
68. Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S. Bisphos-phonate-induced osteopetrosis. N Engl J Med. 2003;349:457-463.
69. Magopoulos C, Karakinaris G, Telioudis Z, Vahtsevanos K, Dimitrakopoulos I, Antoniadis K, et al. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol. 2007;28:158- 163.
70. Brown JJ, Ramalingam L, Zacharin MR. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children [published online ahead of print January 21, 2008]? Clin Endocrinol (Oxf). 2008;68:863-867.
71. Chahine C, Cheung MS, Head TW, Schwartz S, Glorieux FH, Rauch F. Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr. 2008;153:719-720.
72. Ward KA, Adams JE, Freemont TJ, Mughal MZ. Can bisphosphonate treatment be stopped in a growing child with skeletal fragility [published online ahead of print February 6, 2007]? Osteoporos Int. 2007;18:1137-1140.
73. Feldstein AC, Weycker D, Nichols GA, Oster G, Rosales G, Boardman DL, et al. Effectiveness of bisphosphonate therapy in a community setting [published online ahead of print September 26, 2008]. Bone. 2009;44:153-159.